KRAS and cancer: Furthermore, TNTs were shown to transport mutant forms of KRAS to induce ERK signaling in colorectal cancer cells and multidrug resistance P-glycoprotein in multiple cancer types (Ambudkar et al., 2005; Desir et al., 2019).